Biosev S.A. | Cash Flow
Fiscal year is April-March. All values BRL Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,467
499
885
600
1,270
1,199
Depreciation, Depletion & Amortization
650
1,044
1,198
1,538
1,499
1,455
Other Funds
1,188
17
268
108
792
927
Funds from Operations
755
340
602
1,035
580
988
Changes in Working Capital
589
1,121
937
430
1,272
350
Net Operating Cash Flow
1,343
1,462
1,538
605
692
638
Capital Expenditures
1,126
1,084
1,103
1,297
1,097
Sale of Fixed Assets & Businesses
-
-
-
10
-
Purchase/Sale of Investments
441
29
156
286
316
Net Investing Cash Flow
684
1,046
1,259
1,001
1,413
Issuance/Reduction of Debt, Net
373
325
324
99
1,238
Net Financing Cash Flow
279
198
324
99
2,211
Net Change in Cash
938
217
44
298
106
Free Cash Flow
219
384
447
684
1,785
Deferred Taxes & Investment Tax Credit
384
188
20
205
441
195
Change in Capital Stock
651
127
-
-
3,449
About Biosev
View Profile
